<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html><!-- #BeginTemplate "/Templates/basic.dwt" --><!-- DW6 -->

<head>
<!-- #BeginEditable "doctitle" --> 
<title>21-30 ionic minerals selenium dietary supplement research. nutritional 
supplement research.</title>
<meta name="description" content="Dietary supplement, nutritional supplement, diet supplement all selenium research. ionic minerals - selenium mineral supplement and nutrition effects.">
<meta name="keywords" content="ionic minerals,ionic minerals selenium,dietary supplement,nutritional supplement,diet supplement,mineral supplement,selenium research, selenium and prostate cancer">
<meta name="robots" content="index,follow">
<!-- #EndEditable -->
<link rel="stylesheet" href="../../css/maincss.css" type="text/css">
<SCRIPT LANGUAGE="JavaScript" TYPE="text/javascript" SRC="../../javascript/menufirst2.js"></SCRIPT>
</head>

<body link="#0000FF" vlink="#800080" background="../../images/testbck9.gif">

<table border="0" cellpadding="0" width="100%" height="100%" align="center" cellspacing="0">
  <tr>
  <td width="140" height="1" align="center">
    <td valign="top" rowspan="2"><div align="left"><left><table border="0" width="530">
      <tr>
              <td valign="top" align="center" width="100%"><!-- #BeginLibraryItem "/Library/logo_general.lbi" --><p align="center"><img src="../../images/newlogo1.gif" alt="colloidal silver, ionic minerals, MSM, methylsufonylmethane, trace minerals, msm, colloidal silver generator, essential minerals, structured water, natural pet products, alternative health, arthritis pain relief, water filters, mineral supplements, glucosamine, chondroitin" border="0" align="center" width="455" height="60"></p>
<!--#include virtual="/ssi/logo_nature_header.html" --><!-- #EndLibraryItem --><blockquote> <!-- #BeginEditable "content" --> 
                <h3 align="center" class="fonts"><u>Research on the Mineral Selenium</u></h3>
                <p align="left" class="mainfont">The following research abstracts 
                  are presented to reflect the findings of possible benefits from 
                  minerals as a dietary supplement and nutritional supplement. 
                  You will find more on the <a href="../../minerals/selenium.html">ionic 
                  selenium</a> page.</p>
                <h4 align="center" class="fonts"><a name="art21"><font color="#0000AA">Serum 
                  selenium versus lymphocyte subsets and markers of disease progression 
                  and inflammatory response in human immunodeficiency virus-1 
                  infection </font></a></h4>
                <p align="left" class="mainfont">Biological Trace Element Research 
                  (USA), 1997, 56/1 (31-41)</p>
                <p align="left" class="mainfont">Serum <font color="#0088AA">selenium</font> 
                  levels were determined cross-sectionally in 57 HIV- infected 
                  patients who were classified according to the Centers for Disease 
                  Control (CDC) 1993 classification system. Mean serum <font color="#0088AA">selenium</font> 
                  levels were lower in CDC stage II (58.7 plus or minus 12.2 microg/L; 
                  P &lt;0.01; n=&quot;18)&quot; and stage III (47.6 plus or minus 
                  11.3 microg/L; P &lt; 0.01; n=&quot;19)&quot; HIV-infected patients, 
                  than in healthy subjects (80.6 plus or minus 9.6 microg/L; n=&quot;48)&quot; 
                  and stage I patients (73.6 plus or minus 16.5 microg/L; n=&quot;20).&quot; 
                  Serum <font color="#0088AA">selenium</font> levels were positively 
                  correlated with CD4 count, CD4/8 ratio, hematocrit, and serum 
                  albumin (r=&quot;0.42;&quot; r=&quot;0.39;&quot; r=&quot;0.48;&quot; 
                  and r=&quot;0.45;&quot; P &lt; 0.01, respectively) and inversely 
                  with serum levels of thymidine kinase (r=&quot;-&quot; 0.49; 
                  P &lt; 0.01; n=&quot;49)&quot; and beta2-microglobulin (r=&quot;-&quot; 
                  0.46; P &lt; 0.001; n=&quot;49).&quot; In addition, serum <font color="#0088AA">selenium</font> 
                  levels in 20 randomly selected AIDS-free individuals (CDC I: 
                  n=&quot;10;&quot; CDC II: n=&quot;10)&quot; were inversely correlated 
                  with serum concentrations of interleukin-8 (IL-8) and soluble 
                  tumor necrosis factor receptors (sTNFR) types I and II. There 
                  was no correlation with serum immunoglobulin A and total serum 
                  protein levels. The results show that the progressive deprivation 
                  of serum <font color="#0088AA">selenium</font> in HIV- infection 
                  is associated with loss of CD4+-cells and with increased levels 
                  of markers of disease progression and inflammatory response.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art22"><font color="#0000AA">Selenium 
                  and HIV in Pediatrics </font></a></h4>
                <p align="left" class="mainfont">J. NUTR. IMMUNOL. (USA), 1994, 
                  3/1 (41-49)</p>
                <p align="left" class="mainfont">An important role for <font color="#0088AA">selenium</font> 
                  in immune processes has been described, with <font color="#0088AA">selenium</font> 
                  appearing to affect non-specific immune indices, humoral immunity, 
                  cell-mediated immunity and cytotoxicity. Whereas low plasma 
                  <font color="#0088AA">selenium</font> levels have been correlated 
                  with decreased natural killer (NK) cell activity, as well as 
                  proliferative response of lymphocytes to mitogens in vitro, 
                  supplementation with <font color="#0088AA">selenium</font> has 
                  been associated with enhanced lymphocyte response to phytohemagglutinin 
                  (PHA) and pokeweed (PWM) and with enhanced NK activity when 
                  administered in physiological ranges, but not at pharmacological 
                  doses. The investigation of <font color="#0088AA">selenium</font> 
                  status in HIV-1 infection is of particular interest, in light 
                  of studies documenting low plasma <font color="#0088AA">selenium</font> 
                  levels and decreased glutathionine peroxidase activity in adult 
                  patients with AIDS. Moreover, alterations in <font color="#0088AA">selenium</font> 
                  levels have been associated with immune dysregulation in early 
                  HIV-1 infection. As examination of pediatric nutritional status 
                  in HIV-1 disease has been restricted in scope, this study was 
                  designed to characterize <font color="#0088AA">selenium</font> 
                  status and examine its relationship to immune function, in HIV-1 
                  infected children.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art23"><font color="#0000AA">Antioxidant 
                  status and lipid peroxidation in patients infected with HIV 
                  </font></a></h4>
                <p align="left" class="mainfont">CHEM.-BIOL. INTERACT. (Ireland), 
                  1994, 91/2-3 (165-180)</p>
                <p align="left" class="mainfont">Deficiency in antioxidant micronutrients 
                  have been observed in patients with AIDS. These observations 
                  concerning only some isolated nutrients demonstrate a defect 
                  in zinc, <font color="#0088AA">selenium</font>, and glutathione. 
                  An increase in free radical production and lipid peroxidation 
                  has been also found in these patients, and takes a great importance 
                  with recent papers presenting an immunodeficiency and more important 
                  an increase in HIV-1 replication secondary to free radicals 
                  overproduction. We have assessed different studies, trying to 
                  obtain a global view of the antioxidant status of these patients. 
                  In adults we observe a progressive decrease for zinc, <font color="#0088AA">selenium</font>, 
                  and vitamin E with the severity of disease, except that <font color="#0088AA">selenium</font> 
                  remains normal at stage II. However, the main dramatic decrease 
                  concerns carotenoids whose level at stage II is only half the 
                  normal value. To understand if these decreases in antioxidant 
                  and increases in oxidative stress occur secondary to the aggravation 
                  of the disease or, conversely, are responsible for it, we undertook 
                  a longitudinal survey of asymptotic patients. The preliminary 
                  results of this evaluation are presented. Paradoxically, lipid 
                  peroxidation is higher at stage II than at stage IV. This may 
                  be consecutive to a more intense overproduction of oxygen free 
                  radicals by more viable polymorphonuclear (PMN) at the asymptomatic 
                  stage. The free radicals production and lipid peroxidation seem 
                  secondary to a direct induction by the virus of PMN stimulation 
                  and cytokines secretion. N-Acetyl cysteine or ascorbate have 
                  been demonstrated in cell culture to be capable of blocking 
                  the expression of HIV-1 after oxidative stress and N-acetyl 
                  cysteine inhibits in vitro TNF-induced apoptosis of infected 
                  cells. In regard to all these experimental data, few serious 
                  and large trials of antioxidants have been conducted in HIV-infected 
                  patients, although some preliminary studies using zinc or <font color="#0088AA">selenium</font> 
                  have been performed. In our opinion it is now time to evaluate 
                  in humans the beneficial effect of antioxidants. The more promising 
                  candidates for presenting synergistic effects when associated 
                  with N-acetyl cysteine seem to be beta-carotene, <font color="#0088AA">selenium</font> 
                  and zinc.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art24"><font color="#0000AA">Selenium 
                  mediated inhibition of transcription factor NF-kappaB and HIV-1 
                  LTR promoter activity </font></a></h4>
                <p align="left" class="mainfont">Archives of Toxicology (Germany), 
                  1996, 70/5 (277-283)</p>
                <p align="left" class="mainfont">The eukaryotic transcription 
                  factor NF-kappaB is involved in the inducible expression of 
                  various inflammatory genes as well as in HIV-1 replication. 
                  Activation of NF-kappaB is induced by prooxidants and several 
                  stimuli eliciting oxidative stress, such as cytokines, lipopolysaccharide, 
                  UV irradiation and other mediators. Various antioxidants inhibit 
                  NF-kappaB activation in response to these stimuli. In this study, 
                  we have investigated the effects of <font color="#0088AA">selenium</font>, 
                  an integral component of glutathione peroxidase (GPX), on NF-kappaB 
                  activation. In <font color="#0088AA">selenium</font>-deprived 
                  Jurkat and ESb-LT lymphocytes, supplementation of <font color="#0088AA">selenium</font> 
                  led to a substantial increase of GPX activity. Analysis of DNA 
                  binding revealed that NF-kappaB activation in response to TNF 
                  was significantly inhibited under these conditions. Likewise, 
                  reporter gene assays using luciferase constructs driven by the 
                  HIV-1 long terminal repeat showed a dose-dependent inhibition 
                  of NF-kappaB controlled gene expression by <font color="#0088AA">selenium</font>. 
                  The effects of <font color="#0088AA">selenium</font> were specific 
                  for NF-kappaB, since the activity of the transcription factor 
                  AP-1 was not suppressed. These data suggest that <font color="#0088AA">selenium</font> 
                  supplementation may be used to modulate the expression of NF-kappaB 
                  target genes and HIV-1.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art25"><font color="#0000AA">[Diabetes 
                  mellitus--a free radical-associated disease. Results of adjuvant 
                  antioxidant supplementation] </font></a></h4>
                <p align="left" class="mainfont">Z Gesamte Inn Med (GERMANY) May 
                  1993, 48 (5) p223-32</p>
                <p align="left" class="mainfont">Our investigations carried out 
                  in patients with diabetes mellitus revealed oxidative stress 
                  loads. The study presented here was to clarify whether a therapy 
                  with antioxidants can contribute to an improvement of prognosis. 
                  80 patients affected with a long term diabetic late syndrome 
                  were randomised and arranged to 4 groups of n = 20 each. In 
                  contrast to a control group these patients received 600 mg of 
                  alpha lipoic acid or 100 micrograms of <font color="#0088AA">selenium</font> 
                  (sodium selenite) daily or 1200 IE of D-alpha-tocopherol respectively 
                  for a time of 3 months. In comparison with the control group 
                  all groups treated in an antioxidative way showed significantly 
                  diminished serum concentrations of thiobarbituric acid reactive 
                  substances and of urinary albumin excretion rates. The symptoms 
                  of distal symmetric neuropathy measured according to the thermo- 
                  and vibration sensitivity also improved in a highly significant 
                  manner. The results prove that oxidative stress plays a promoting 
                  role in developing of long term diabetic late complications 
                  and that a therapy with adjuvant antioxidants may lead to a 
                  regression of diabetic late complications.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art26"><font color="#0000AA">Biochemical 
                  and morphological changes in the lenses of selenium and/or vitamin 
                  E deficient rats. </font></a></h4>
                <p align="left" class="mainfont">Biomed Environ Sci (UNITED STATES) 
                  Jun 1994, 7 (2) p109-15</p>
                <p align="left" class="mainfont">The activities of glutathione 
                  peroxidase (GSH-Px), glutathione reductase (GSSG-R), superoxide 
                  dismutase (SOD) and the contents of malondialdehyde (MDA) and 
                  free radicals were measured, and the morphological changes were 
                  observed in the lens of control rats, <font color="#0088AA">selenium</font>-deficient 
                  (SeD) and/or vitamin E deficient (VED) rats. The activities 
                  of GSH-Px in the lens of SeD rats decreased significantly. The 
                  GSH-Px activities of lens were positively related to erythrocytes 
                  <font color="#0088AA">selenium</font> level. There was a free 
                  radical at g = 2.0015 in the rat lens of all groups, but the 
                  content of free radicals in the lens of SeD group was significantly 
                  higher than that of the control group. The free radical content 
                  of lens was negatively related to erythrocytes <font color="#0088AA">selenium</font> 
                  level, as well as the GSH-Px activities in the lens. In vitro, 
                  ultraviolet radiation caused the generation of another kind 
                  of free radical (g = 2.0097) in the lens of all groups, but 
                  the amount of the free radical in the lens of the SeD group 
                  was also significantly higher than that of the control group. 
                  The activities of SOD and GSSG-R in VED rat lens were significantly 
                  decreased. The amount of MDA in the lens of SeD and/or VED rats 
                  were significantly increased. The results showed that the decrease 
                  of antioxidative capability in the lenses of SeD and/or VED 
                  rats accelerated the lipid peroxidation and generation of free 
                  radicals. Although only early morphological changes in SeD and/or 
                  VED rat lens were observed, it is considered that <font color="#0088AA">selenium</font> 
                  and vitamin E deficiency may be involved in the occurrence of 
                  cataract.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art27"><font color="#0000AA">Myopathy 
                  and HIV infection </font></a></h4>
                <p align="left" class="mainfont">Current Opinion in Rheumatology 
                  (USA), 1995, 7/6 (497-502)</p>
                <p align="left" class="mainfont">Skeletal muscle involvement may 
                  occur at all stages of HIV infection. The most simple classification 
                  of muscular disorders in HIV-infected patients is 1) HIV-associated 
                  myopathies, 2) zidovudine myopathy, 3) HIV wasting syndrome, 
                  and 4) opportunistic infections and tumoral infiltrations of 
                  muscle. Immunohistology for major histocompatibility complex 
                  class 1 antigen and histochemical reaction for cytochrome c 
                  oxidase are helpful in correctly classifying a myopathy as HIV 
                  polymyositis or zidovudine myopathy. Studies of cytokine expression 
                  in HIV-infected patients and of supplementation with compounds 
                  such as carnitine or micronutrients such as <font color="#0088AA">selenium</font> 
                  might yield new insights into the pathogenesis and treatment 
                  of the various AIDS- associated muscular disorders.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art28"><font color="#0000AA">Protective 
                  role of orally administered selenium and vitamin E towards cardiotoxicity 
                  induced by anthracyclines in the rat </font></a></h4>
                <p align="left" class="mainfont">Nutrition Clinique et Metabolisme 
                  (France), 1996, 10/2 (69-76)</p>
                <p align="left" class="mainfont">Adriamycin-induced cardiotoxicity 
                  could be due to free radical formation, which induces lipid 
                  peroxidation and membrane damage. We have studied the effect 
                  of oral supplementation with <font color="#0088AA">selenium</font> 
                  (Se) and/or vitamin E (Vit. E) on myocardiopathy in rats treated 
                  by adriamycin (ADM). Animals were divided into groups by ADM 
                  (ADM) or NaCl 0.15 M solution (Control group = C); standard 
                  diet (SD); ADM I and C I; SD with Se; ADM II and C II; SD with 
                  Vit. E; ADM III and C III; SD with Se and Vit. E; ADM IV and 
                  C IV. All rats received ADM or saline solution by the intraperitoneal 
                  route. Ascitis and survival were observed throughout 18 weeks 
                  and hearts were studied histologically. Survival was 100% for 
                  controls while median survival was 12 (ADM I and II), 14 (ADM 
                  III) and 16 weeks (ADM IV) in treated rats. Ascitis was significantly 
                  less marked in ADM IV compared with ADM I (p = 0.02). Heart 
                  weight was decreased in ADM I, II and III compared with those 
                  of controls (p = 0.001) while it was similar to controls in 
                  ADM IV. Cardiac lesions studied by semi-quantitative histology 
                  were less severe in ADM IV. Se associated with Vit. E could 
                  prevent cardiac toxicity induced by ADM treatment and may be 
                  helpful to clinicians in chemotherapy using anthracycline.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art29"><font color="#0000AA">Enhancement 
                  of the antineoplastic effect of anticarcinogens on benzo[a]pyrene-treated 
                  Wistar rats, in relation to their number and biological activity. 
                  </font></a></h4>
                <p align="left" class="mainfont">Cancer Lett. 1994 Jul 29. 82(2). 
                  P 153-65</p>
                <p align="left" class="mainfont">Naturally occurring anticarcinogens, 
                  such as vitamins C and E, and the microelement <font color="#0088AA">selenium</font> 
                  were found to inhibit the induction of benzo[a]pyrene-induced 
                  malignant tumors in Wistar rats to various extends. The antineoplastic 
                  effect of the tested anticarcinogens is gradually increased 
                  according to the number of inhibitors selected. To date the 
                  maximum action against malignancy is manifested by use of the 
                  above three inhibitors. In the group of rats receiving vitamins 
                  C, E and <font color="#0088AA">selenium</font>, the prolongation 
                  of life induced by adding more than one anticarcinogen to the 
                  treatment regime reached, and in some cases surpassed, the normal 
                  life expectancy of the rats. It is expected that by adding even 
                  more anticarcinogens, the antineoplastic potency (Ap) of the 
                  inhibitors will be further improved. These results encouraged 
                  us to conduct a clinical trial in terminal human cancer cases, 
                  in conjunction with the usual treatments of surgery or chemotherapy 
                  and irradiation.</p>
                <p align="center" class="mainc"><a href="./"><img src="../../images/back.gif" border="0" width="42" height="10"></a></p>
                <h4 align="center" class="fonts"><a name="art30"><font color="#0000AA">Critical 
                  reappraisal of vitamins and trace minerals in nutritional support 
                  of cancer patients. </font></a></h4>
                <p align="left" class="mainfont">Support Care Cancer. 1993 Nov. 
                  1(6). P 295-7</p>
                <p align="left" class="mainfont">The potential of a high intake 
                  of fresh fruits and vegetables in cancer prevention is well 
                  established. Epidemiological studies support carotene, vitamins 
                  A, C, E and <font color="#0088AA">selenium</font> as the active 
                  compounds. Antioxidant properties and direct effects (e.g. inhibition 
                  of N-nitrosamine formation or cell-to-cell interactions) are 
                  invoked. The role of other trace elements is less clear. The 
                  modulation of immune function by vitamins and trace elements 
                  remains important and affects survival. In established cancers, 
                  the site-specific differences in the diet/cancer relation require 
                  appropriate dietary changes, e.g. low fat (20% by energy) in 
                  breast cancer, or high vegetable or fruit intake in lung cancer. 
                  Single high-dose supplements (e.g. vitamin C) have proved to 
                  have no curative or life-prolonging effect. Chemotherapy and 
                  radiation increase the requirements for antioxidant compounds. 
                  Supplementation can diminish the damage induced by peroxidation. 
                  Carefully planned and monitored trials that establish the optimal 
                  intake of micronutrients as adjuvants in cancer patients are 
                  required.</p>
                <p align="center"><a href="./"><img src="../../images/back.gif" alt="back.gif" border="0" width="42" height="10"></a></p>
                <table border="1">
                  <tr> 
                    <td align="center" class="mainfont" height="19"><a href="../">See 
                      More Research</a></td>
                  </tr>
                  <tr> 
                    <td align="center" class="mainfont"><a href="../../minerals/selenium.html">Go 
                      to Ionic Selenium Page</a></td>
                  </tr>
                </table>
                <!-- #EndEditable --> 
              </blockquote>
                  
                
              
                <!-- #BeginLibraryItem "/Library/link_tree.lbi" --><!--#include virtual="/ssi/link_tree.html"--><!-- #EndLibraryItem --><p align="center"><br></p>
		        <blockquote><!-- #BeginLibraryItem "/Library/disclaimer.lbi" --><!--#include virtual="/ssi/disclaimer.html"--><!-- #EndLibraryItem --><!-- #BeginLibraryItem "/Library/copyright.lbi" --><!--#include virtual="/ssi/copyright.html"-->
<hr width="90%">
<!--#include virtual="/ssi/footer_address.html"--><!-- #EndLibraryItem --></blockquote>
</td>
      </tr>
    </table>
    </left></div></td></tr><tr>
	<!--START LEFT SIDE MENU-->
    <td valign="top" width="140" align="left">
	 <table border="0" cellpadding="0" width="140" cellspacing="0">
      <tr>
          <td><!-- #BeginLibraryItem "/Library/navbar.lbi" --><!--#include virtual="/ssi/navbar.html"--><!-- #EndLibraryItem --></td>
      </tr>
    </table>
    </td>
<!--END LEFT SIDE MENU-->
  </tr>
</table>
</body>
<!-- #EndTemplate --></html>
